Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Members of the CEACAM subfamily, including CEACAM5, belong to the CEA gene family. Additionally we are shipping CEACAM5 Proteins (11) and CEACAM5 Kits (10) and many more products for this protein.
Showing 10 out of 436 products:
Human Monoclonal CEACAM5 Primary Antibody for cELISA, FACS - ABIN108727
Baczy?ska, Wietrzyk, Madej, Krop-Watorek, Dabrowska, Widerak, Opolski, Ugorski: The tumorigenic potential of human CX-1 colon adenocarcinoma cells depends on carcinoembryonic antigen (CEACAM5) expression. in Cellular & molecular biology letters 2003
Show all 14 references for ABIN108727
Human Monoclonal CEACAM5 Primary Antibody for ELISA, IF (p) - ABIN722946
Yu, Zhan, Liu, Lv, Duan: Plasma-enhanced antibody immobilization for the development of a capillary-based carcinoembryonic antigen immunosensor using laser-induced fluorescence spectroscopy. in Analytical chemistry 2013
Show all 8 references for ABIN722946
Human Monoclonal CEACAM5 Primary Antibody for cELISA, FACS - ABIN108734
Grunert, AbuHarfeil, Schwarz, von Kleist: Two CEA and three NCA species, although distinguishable by monoclonal antibodies, have nearly identical peptide patterns. in International journal of cancer. Journal international du cancer 1985
Show all 5 references for ABIN108734
Human Polyclonal CEACAM5 Primary Antibody for IHC (fro), IHC (p) - ABIN115285
Nap, Keuning, Burtin, Oosterhuis, Fleuren: CEA and NCA in benign and malignant breast tumors. in American journal of clinical pathology 1984
Show all 2 references for ABIN115285
Human Monoclonal CEACAM5 Primary Antibody for FACS - ABIN319988
Price: Epitopes of carcinoembryonic antigen (CEA) defined by monoclonal antibodies. in British journal of cancer 1988
Show all 2 references for ABIN319988
Human Monoclonal CEACAM5 Primary Antibody for IHC (p), WB - ABIN1106531
GOLD, FREEDMAN: DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. in The Journal of experimental medicine 1970
Show all 2 references for ABIN1106531
Human Polyclonal CEACAM5 Primary Antibody for EIA, WB - ABIN452835
Lagoudianakis, Kataki, Manouras, Memos, Papadima, Derventzi, Zografos, Papadopoulos, Katergiannakis, Konstadoulakis: Detection of epithelial cells by RT-PCR targeting CEA, CK20, and TEM-8 in colorectal carcinoma patients using OncoQuick density gradient centrifugation system. in The Journal of surgical research 2009
Show all 2 references for ABIN452835
Data show that carcinoembryonic antigen (CEA) modestly differentiated between mucinous and nonmucinous lesions, and amylase (show AMY Antibodies) did not distinguish intraductal papillary mucinous neoplasms (IPMNs) from mucinous cystadenomas (MCAs).
In this study, we detected the tumor marker carcinoembryonic antigen (CEA) using the QD-LFTS system, which allowed quantitative analysis in the range of 1-100ng/mL with an ideal detection limit of 0.049ng/mL. Thus, the system is suitable for detecting CEA in the clinically accepted range. We also detected 70 positive and 30 negative serum samples using the Handing system, which exhibited good specificity and sensitivity.
As a proof-of-concept study, the constructed platform exhibits good specificity for CEA and the detection limit reaches as low as 8pg/mL (45 fM) with a wide linear range from 0.01 to 60ng/mL in the both cases
Under the optimal conditions, the proposed immunosensor was used for the detection of CEA with wide dynamic range in the range from 5 fg/mL to 50ng/mL with a low detection limit of 2fg/mL (S/N=3).
Relative CL intensity of all-in-one dual-aptasensor, operated with the competitive reaction of CEA and hemin in the presence of the dual aptamer, was exponentially decreased with the increase of CEA concentration in human serum
Data indicate that serum tumor markers showed significant shorter 3-year progression-free survival (PFS) in higher levels compared to lower levels for S-CYFRA 21-1 (cytokeratin 19 (show KRT19 Antibodies) fragment), S-SCCA and S-CEA.
Multivariate logistic regression analysis revealed TC and DeltaCEA as independent factors in predicting TRG; TC showed a sensitivity of 62.79 %, a specificity of 91.49 %, a Youden index of 0.543, a cutoff value of 5.52, and an AUC of 0.800 compared with DeltaCEA (sensitivity 76.74 %, specificity 65.96 %, Youden index 0.427, and AUC 0.761).
Data suggest that joint detection of receptor-binding cancer antigen expressed on SiSo cells (RCAS1 (show EBAG9 Antibodies)) and carcinoembryonic antigen (CEA) can improve the diagnostic sensitivity and specificity.
High CEA level is associated with Oral Squamous Cell Carcinoma.
High CEA expression is associated with metastasis and recurrence in endometrial cancer.
a new mechanistic insight into how the CEA (show CEA Antibodies) IgV-like N domain participates in cellular events that can have a macroscopic impact in terms of cancer progression and metastasis.
Members of the CEACAM subfamily, including CEACAM5, belong to the CEA gene family. For general information on the CEA gene family, see CEACAM1 (MIM 109770).
carcinoembryonic antigen-related cell adhesion molecule 5
, carcinoembryonic antigen
, carcinoembryonic antigen-related cell adhesion molecule 5-like
, CEA-related cell adhesion molecule 20
, meconium antigen 100
, pregnancy-specific glycoprotein 30